Rallying around Start-Ups struggling in COVID-19 pandemic. MMG - Mike Margiotta Group is a privately owned Consulting Group launching in response to the fallout from the spread of coronavirus infections.
Read Press ReleaseThe Virtual Center for Velo-Cardio-Facial Syndrome collaborates with the Center for Precision Neuropsychiatry based in the Department of Psychiatry at Columbia University Vagelos College of Physicians and Surgeons
Read Press ReleaseThe European clinical laboratory services market surpassed USD 49 billion in 2018 and is set to achieve a significant CAGR up to 2025, driven by well-equipped healthcare infrastructure.
Read Press ReleaseElastic Adhesive Tape is ideal for stabilizing joints, tendons and ligaments during vigorous exercise. Firmly wrap around the ankle, wrist, or any other highly-used joint to prevent injury caused by muscle stress and fatigue.
Read Press ReleaseThis report studies the global market size of Capsule Filler Machine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
Read Press ReleaseThis report studies the global market size of 3D Scanners for Orthopedic, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
Read Press ReleaseThis report studies the global market size of Nasal Oxygen Tubes and especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
Read Press ReleaseHemoglobin A1C analyzer is the determination of glycosylated hemoglobin (HbA1c) and can reflect the degree of hemoglobin and glucose binding instrument. Glycosylated hemoglobin is a good indicator of the disease control degree of diabetes patients and can reflect the level of stage blood glucose. HbA1c, an effective indicator for screening, diagnosis, blood glucose control and efficacy assessment of diabetes, has been widely used in clinical practice.
Read Press ReleaseConcept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), its Sirolimus drug-coated balloon (DCB) catheter, for the treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK). The first 'Breakthrough Device Designation' received by Concept Medical Inc. was on 30th April 2019 for its MagicTouch SCB, for the treatment of Coronary Artery Disease (CAD) in patients with in-stent restenosis.
Read Press Release